Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Bryan C Hanson is Chief Executive Officer at Solventum. OQRO lists 10 transactions filed with the SEC under this name, the latest on Sep 3, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
10
Companies involved
1
SolventumSOLV
10 disclosures · Mar 2026 – Sep 2026
Sep 1, 202667Kdisclosed Sep 3
DetailsOfficial recordSep 1, 202667Kdisclosed Sep 3
DetailsOfficial recordSep 1, 202626Kdisclosed Sep 3
DetailsOfficial recordMay 13, 202634Kdisclosed May 15
DetailsOfficial recordMay 13, 202634Kdisclosed May 15
DetailsOfficial recordMay 13, 202614Kdisclosed May 15
DetailsOfficial recordMar 5, 2026106Kdisclosed Mar 9
DetailsOfficial recordMar 6, 202632Kdisclosed Mar 9
DetailsOfficial recordMar 6, 202632Kdisclosed Mar 9
DetailsOfficial recordMar 6, 202610Kdisclosed Mar 9
DetailsOfficial recordBryan C Hanson bought shares on the open market in 2018, 2019 and 2020, and has not bought since 2020 across 2 companies. Sales in 2 of the 11 years since 2016.
Bryan C Hanson reported 9 open-market purchases and 10 sales since 2016; purchases in 3 different years, most recently 2020.
| Year | Bought | Sold |
|---|---|---|
| 2020 | $113K1×1 trade | — |
| 2019 | $250K3×3 trades | — |
| 2018 | $3.05M5×5 trades | — |
| 2017 | — | $4.9M4×4 trades |
| 2016 | — | $5.07M6×6 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Bryan C Hanson reported holding 185,515 shares of Solventum (SOLV), worth about $15.9M at the last close of $86 (Nov 19, 2026).
Solventum's proxy statement reports total compensation of $20.1M for Bryan C Hanson for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Mar 27, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Solventum SOLV | 185,515 | 186K direct | $86 | $15.9M | Sep 1, 2026 |
Is this Bryan C Hanson’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Sep 1, 2026, Bryan C Hanson reported holding 185,515 shares of Solventum (SOLV). At the last close of $86 on Nov 19, 2026, that is about $15.9M. This is the stake disclosed in filings, not a net worth.
No public filing gives Bryan C Hanson's net worth. What SEC Form 4 shows is the stock stake: 185,515 shares of Solventum (SOLV), about $15.9M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Solventum's proxy statement reports total compensation of $20.1M for Bryan C Hanson for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Bryan C Hanson bought shares on the open market in 2018, 2019 and 2020, and has not bought since 2020 across 2 companies. Sales in 2 of the 11 years since 2016.
In SEC filings since 2016: the latest open-market purchase is from 2020; the latest open-market sale is from 2017.
2 companies: Zimmer Biomet (ZBH, 2018–2020), Medtronic (MDT, 2016–2017).
Bryan C Hanson reported 0 open-market purchases and 10 sales here, 2016 to 2017.
Bryan C Hanson reported 9 open-market purchases and 0 sales here, 2018 to 2020.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.